762757

539997

KPL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Kwality Pharmaceuticals L Share Price Today

KWALITY PHARMACEUTICALS L made its stock market debut on 20 April 2026 and is currently trading at ₹2424.7, down by ₹60.5 from the previous close. The stock touched an intraday high of ₹2499.90 and a low of ₹2404.10 during the latest trading session.

Kwality Pharmaceuticals L performance

Today’s low Today’s high
₹ 2404.10 ₹ 2499.90
₹ 2423.00
52 week low 52 week high
₹ 1561.00 ₹ 2600.00
₹ 2423.00
Open Price ₹ 2475.70
Prev. Close ₹ 2485.20
Volume (Shares) 24679.00
Total traded value ₹ 597.97
Upper Circuit ₹ 2982.20
Lower Circuit ₹ 1988.20
info

Investment Returns

Over 1 Month 24.21% Over 3 Months 49.47% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Kwality Pharmaceuticals L fundamentals


  • Market cap (Cr) 2,514.20
  • P/E Ratio (TTM) 38.26
  • Beta 0.97
  • Book Value / share 320.51
  • Return on equity 16.27%
  • EPS (TTM) 65.50
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 25.29
info icon alternate text
  • Market cap (Cr) 2,505.90
  • P/E Ratio (TTM) 38.26
  • Beta 0.67
  • Book Value / share 320.51
  • Return on equity 16.27%
  • EPS (TTM) 65.50
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 25.29
info icon alternate text

Kwality Pharmaceuticals L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 156.82
Operating Expense 126.23
Net Profit 25.29
Net Profit Margin (%) 16.12
Earnings Per Share (EPS) 24.37
EBITDA 39.80
Effective Tax Rate (%) 20.09
Particulars DEC 2025 (Values in Cr)
Revenue 123.44
Operating Expense 100.79
Net Profit 16.01
Net Profit Margin (%) 12.96
Earnings Per Share (EPS) 15.43
EBITDA 29.65
Effective Tax Rate (%) 28.41
Particulars SEP 2025 (Values in Cr)
Revenue 111.31
Operating Expense 93.76
Net Profit 14.12
Net Profit Margin (%) 12.68
Earnings Per Share (EPS) 13.60
EBITDA 26.25
Effective Tax Rate (%) 23.46
Particulars JUN 2025 (Values in Cr)
Revenue 111.48
Operating Expense 94.81
Net Profit 11.93
Net Profit Margin (%) 10.70
Earnings Per Share (EPS) 11.50
EBITDA 24.55
Effective Tax Rate (%) 29.98
Particulars MAR 2025 (Values in Cr)
Revenue 115.68
Operating Expense 97.35
Net Profit 14.50
Net Profit Margin (%) 12.53
Earnings Per Share (EPS) 13.97
EBITDA 26.65
Effective Tax Rate (%) 24.04
Particulars MAR 2026 (Values in Cr)
Revenue 503.06
Operating Expense 415.60
Net Profit 67.35
Net Profit Margin (%) 13.38
Earnings Per Share (EPS) 64.90
EBITDA 120.25
Effective Tax Rate (%) 24.75
Particulars MAR 2025 (Values in Cr)
Revenue 370.20
Operating Expense 317.89
Net Profit 39.89
Net Profit Margin (%) 10.77
Earnings Per Share (EPS) 38.44
EBITDA 82.37
Effective Tax Rate (%) 26.44
Particulars MAR 2024 (Values in Cr)
Revenue 307.17
Operating Expense 270.44
Net Profit 23.98
Net Profit Margin (%) 7.80
Earnings Per Share (EPS) 23.11
EBITDA 61.37
Effective Tax Rate (%) 23.76
Particulars MAR 2023 (Values in Cr)
Revenue 250.99
Operating Expense 211.64
Net Profit 19.47
Net Profit Margin (%) 7.75
Earnings Per Share (EPS) 18.45
EBITDA 46.70
Effective Tax Rate (%) 24.41
Particulars MAR 2022 (Values in Cr)
Revenue 456.13
Operating Expense 297.97
Net Profit 120.05
Net Profit Margin (%) 26.31
Earnings Per Share (EPS) 115.70
EBITDA 175.22
Effective Tax Rate (%) 25.74
Particulars MAR 2025 (Values in Cr)
Book Value / Share 253.70
ROE % 16.36
ROCE % 18.35
Total Debt to Total Equity 0.43
EBITDA Margin 22.23
Particulars MAR 2024 (Values in Cr)
Book Value / Share 215.31
ROE % 13.66
ROCE % 15.86
Total Debt to Total Equity 0.45
EBITDA Margin 22.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share 192.48
ROE % 16.57
ROCE % 18.50
Total Debt to Total Equity 0.38
EBITDA Margin 25.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 173.81
ROE % 99.66
ROCE % 94.93
Total Debt to Total Equity 0.40
EBITDA Margin 38.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 58.16
ROE % 28.21
ROCE % 23.78
Total Debt to Total Equity 0.72
EBITDA Margin 11.62
Particulars MAR 2025 (Values in Cr)
Book Value / Share 255.44
ROE % 16.27
ROCE % 18.29
Total Debt to Total Equity 0.43
EBITDA Margin 22.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 216.98
ROE % 13.74
ROCE % 15.90
Total Debt to Total Equity 0.44
EBITDA Margin 22.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 193.93
ROE % 16.56
ROCE % 18.47
Total Debt to Total Equity 0.38
EBITDA Margin 25.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 175.17
ROE % 98.62
ROCE % 94.24
Total Debt to Total Equity 0.39
EBITDA Margin 38.42
Particulars MAR 2021 (Values in Cr)
Book Value / Share 59.47
ROE % 28.55
ROCE % 23.96
Total Debt to Total Equity 0.71
EBITDA Margin 11.80
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 14.75
Total Assets 447.27
Total Liabilities 447.27
Total Equity 262.39
Share Outstanding 1
Price to Book Ratio 3.40
Return on Assets (%) 8.90
Return on Capital (%) 10.63
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.94
Total Assets 394.20
Total Liabilities 394.20
Total Equity 222.58
Share Outstanding 1
Price to Book Ratio 1.89
Return on Assets (%) 6.03
Return on Capital (%) 7.42
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.36
Total Assets 353.63
Total Liabilities 353.63
Total Equity 199.06
Share Outstanding 1
Price to Book Ratio 1.59
Return on Assets (%) 5.47
Return on Capital (%) 6.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.95
Total Assets 340.59
Total Liabilities 340.59
Total Equity 179.78
Share Outstanding 1
Price to Book Ratio 3.31
Return on Assets (%) 35.23
Return on Capital (%) 51.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.80
Total Assets 166.26
Total Liabilities 166.26
Total Equity 59.85
Share Outstanding 1
Price to Book Ratio 0.94
Return on Assets (%) 9.10
Return on Capital (%) 16.02
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 14.28
Total Assets 450.72
Total Liabilities 450.72
Total Equity 265.84
Share Outstanding 1
Price to Book Ratio 3.40
Return on Assets (%) 8.85
Return on Capital (%) 10.54
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.03
Total Assets 397.57
Total Liabilities 397.57
Total Equity 225.94
Share Outstanding 1
Price to Book Ratio 1.89
Return on Assets (%) 6.03
Return on Capital (%) 7.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.09
Total Assets 356.58
Total Liabilities 356.58
Total Equity 202.02
Share Outstanding 1
Price to Book Ratio 1.59
Return on Assets (%) 5.45
Return on Capital (%) 6.66
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 10.87
Total Assets 342.67
Total Liabilities 342.67
Total Equity 182.55
Share Outstanding 1
Price to Book Ratio 3.31
Return on Assets (%) 35.03
Return on Capital (%) 50.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.13
Total Assets 168.78
Total Liabilities 168.78
Total Equity 62.50
Share Outstanding 1
Price to Book Ratio 0.94
Return on Assets (%) 9.13
Return on Capital (%) 15.85
Particulars MAR 2025 (Values in Cr)
Net Income 54.13
Cash from Operations 68.50
Cash from Investing -28.51
Cash from Financing -14.44
Net change in Cash 9.76
Free Cash Flow 91.80
Particulars MAR 2024 (Values in Cr)
Net Income 31.09
Cash from Operations 44.28
Cash from Investing -26.39
Cash from Financing -17.39
Net change in Cash -0.81
Free Cash Flow 74.12
Particulars MAR 2023 (Values in Cr)
Net Income 25.57
Cash from Operations 47.53
Cash from Investing -48.44
Cash from Financing 0.99
Net change in Cash -6.06
Free Cash Flow 95.21
Particulars MAR 2022 (Values in Cr)
Net Income 161.56
Cash from Operations 101.95
Cash from Investing -62.92
Cash from Financing 5.65
Net change in Cash 3.32
Free Cash Flow 157.10
Particulars MAR 2021 (Values in Cr)
Net Income 21.27
Cash from Operations 33.08
Cash from Investing -23.20
Cash from Financing 0.76
Net change in Cash 4.27
Free Cash Flow 56.48
Particulars MAR 2025 (Values in Cr)
Net Income 54.22
Cash from Operations 68.56
Cash from Investing -28.13
Cash from Financing -14.44
Net change in Cash 10.20
Free Cash Flow 91.47
Particulars MAR 2024 (Values in Cr)
Net Income 31.46
Cash from Operations 44.64
Cash from Investing -26.39
Cash from Financing -17.39
Net change in Cash -0.44
Free Cash Flow 74.48
Particulars MAR 2023 (Values in Cr)
Net Income 25.76
Cash from Operations 48.34
Cash from Investing -48.44
Cash from Financing 0.99
Net change in Cash -5.25
Free Cash Flow 96.01
Particulars MAR 2022 (Values in Cr)
Net Income 161.67
Cash from Operations 100.59
Cash from Investing -62.97
Cash from Financing 5.65
Net change in Cash 1.92
Free Cash Flow 155.75
Particulars MAR 2021 (Values in Cr)
Net Income 21.79
Cash from Operations 32.73
Cash from Investing -23.19
Cash from Financing 0.82
Net change in Cash 3.98
Free Cash Flow 56.13
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

Kwality Pharmaceuticals L shareholding pattern

Holding
41.98%
54.86%
2.78%
0.35%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Kwality Pharmaceuticals L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
2423.00 -2.50 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 2413.40
  • 26 Days 2215.30
  • 10 Days 2386.70
  • 50 Days 2004.70
  • 12 Days 2370.70
  • 100 Days 2004.70
  • 20 Days 2290.80
  • 200 Days 2004.70
2448.40 PIVOT
First Support 2396.80 First Resistance 2536.80 Second Support 2308.40 Second Resistance 2588.40 Third Support 2256.80 Third Resistance 2676.80
RSI 64.05 ADX 75.42 MACD 155.46 Williams % R -27.33 Commodity Channel Index (CCI) 96.00
Date 2026-06-19 Week 15547.00 Same Day 16536.00 Month 24557.00
1 Year 0.97 3 Year 0.90
Over 1 Month
24.21% down
Over 1 Year
0.00% down
Over 3 Months
49.47% down
Over 3 Years
0.00% down
Over 6 Months
0.00% down
Over 5 Years
0.00% down

Kwality Pharmaceuticals L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
05 Jan 2017 0.6 Interim 06 Jan 2017 Equity shares
Ex-Date Ex-Bonus Ratio
12 Oct 2017 11 Oct 2017 1:1
Dividend date Dividend amount Dividend type Record date Instrument type
05 Jan 2017 0.6 Interim 06 Jan 2017 Equity shares
Ex-Date Ex-Bonus Ratio
12 Oct 2017 11 Oct 2017 1:1

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Kwality Pharmaceuticals Ltd?

Answer Field

Kwality Pharmaceuticals Ltd share price is for NSE ₹ 2,424.70 & for BSE ₹ 2,412.00 as on Jun 22 2026 03:29 PM.

What is the Market Cap of Kwality Pharmaceuticals Ltd Share?

Answer Field

The market cap of Kwality Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 22 2026 03:29 PM.

What is the 52 Week High and Low of Kwality Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Kwality Pharmaceuticals Ltd for NSE is ₹ 2,600.00 and ₹ 1,561.00 and for BSE is ₹ 2,600.00 and ₹ 828.80.

What is 1 year return for Kwality Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Kwality Pharmaceuticals Ltd Share?

Answer Field

As on Jun 22 2026 03:29 PM the price-to-earnings (PE) ratio for Kwality Pharmaceuticals Ltd share is 38.26.

What is the PB ratio of Kwality Pharmaceuticals Ltd Share?

Answer Field

As on Jun 22 2026 03:29 PM, the price-to-book (PB) ratio for Kwality Pharmaceuticals Ltd share is 320.51.

How to Buy Kwality Pharmaceuticals Ltd Share?

Answer Field

You can trade in Kwality Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kwality Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Kwality Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kwality Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|